shares on issue, page-7

Lucky I purchased at 40 cents around 18 months ago. I do feel sorry for other longer term holders. I really feel uneasy about this spin off company. If the Oncology arm of the company produces results below par, it will get smashed. Then you have Fonda which is a one product company - bad news.

It's a real shame what has happened to this company since FDA approval. In terms of both share price decline and overall progress of the company. It's a tough market out there, but I can not say I'm too pleased with management.

I remember reading this forum about FDA approval party and the expected profits due to share price accelerating. Now it's more like counting the dollars lost.